Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with promising anti-melanoma activity: biological and computational studies
A series of imidazothiazole derivatives possessing potential activity against melanoma cells were investigated for molecular mechanism of action. The target compounds were tested against V600E-B-RAF and RAF1 kinases. Compound 1zb is the most potent against both kinases with IC50 values 0.978 and 8.2...
Main Authors: | Hanan S. Anbar, Mohammed I. El-Gamal, Hamadeh Tarazi, Bong S. Lee, Hong R. Jeon, Dow Kwon, Chang-Hyun Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14756366.2020.1819260 |
Similar Items
-
Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors
by: Marta Serafini, et al.
Published: (2019-05-01) -
Synthesis and antimicrobial activity of some imidazothiazole derivatives of benzofuran
by: Sheelavanth Shankerrao, et al.
Published: (2017-02-01) -
Novel natural inhibitors targeting B-RAF(V600E) by computational study
by: Bo Wu, et al.
Published: (2021-01-01) -
Determinación de la mutación BRAF V600E en melanomas de pacientes uruguayos
by: María Eugenia Mazzei, et al.
Published: (2013-06-01) -
Heme oxygenase 1 facilitates cell proliferation via the B-Raf-ERK signaling pathway in melanoma
by: Liu Liu, et al.
Published: (2019-01-01)